The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
电子烟气溶胶暴露对非人灵长类动物先天肺防御机制的影响
基本信息
- 批准号:10428016
- 负责人:
- 金额:$ 20.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
Vaping is a serious public health concern that was associated with outbreaks of hospitalizations and deaths in
2019. These outbreaks of electronic vaping associated lung injury (EVALI) coincided with increased use of
electronic vaping devices by adolescents and young adults. The rapid disease onset of EVALI and the role of
macrophages in its progression, support a role for the innate immune system in the pathogenesis of EVALI.
Despite its rising use little is currently known about the effect of vaping on pulmonary immunology and physiology
highlighting the need for animal models to better understand its effects. Small animal models have shown
pathologic changes following exposure to vaping aerosols; however, they do not recapitulate the pathologic
manifestations of EVALI reported in humans necessitating a more translatable animal model to investigate the
pathogenesis of EVALI. Nonhuman primates (NHPs) are ideally suited for studying respiratory diseases in
humans due to their similarity in both pulmonary anatomy and immunology which provide advantages over other
animal models. Here, we aim to utilize a NHP model to investigate the impact of vaping aerosol exposure on
innate pulmonary defense mechanisms. We will longitudinally assess pulmonary and innate immune function
(immune cell infiltrates, alveolar macrophage phagocytosis, and secretion of cytokines, chemokines, and
defense molecules) over a four-week period of daily vaping aerosol exposure. At the end of the study, correlation
with pathologic changes will occur through rigorous postmortem examination and sampling of the upper and
lower respiratory tract. The data generated from this study will inform on mechanisms by which vaping aerosols
effect innate pulmonary defenses, an important area of investigation in this time of highly infectious respiratory
diseases. Furthermore, this study will provide preliminary data for future investigations evaluating the contribution
of individual constituents within the vaping liquid (nicotine, tetrahydrocannabinol, and vitamin E acetate); and
vaping in the context of comorbid conditions (SARS-CoV-2 and HIV/SIV), areas of special interest supported by
several funding agencies (NIDA, NHLBI, NIAID). This proposed study and Mentored Career Development Plan
will be conducted at the Tulane National Primate Research Center under the guidance of Drs. Ronald Veazey
and Chad Roy. The TNPRC has been a national resource and center of excellence for biomedical research
using nonhuman primates for over 50 years. The TNPRC has a strong commitment to training and mentorship
and provides support (financial and effort-based) to create a rich and diverse training environment for early-stage
investigators. The TNPRC fully supports Dr. Blair in his career goal to develop into an independently funded
private investigator working with NHP models to study diseases of major public health importance. The dedicated
time and additional mentorship provided by this K01 will help Dr. Blair refine his grant writing and project
management skills to ensure the success of his future R01 proposals.
项目摘要
烟是一个严重的公共卫生问题,与住院和死亡的爆发有关
2019年。这些电子蒸发相关的肺损伤的暴发(evali)与使用的使用增加相吻合
青少年和年轻人的电子蒸发设备。评估的快速疾病发作和
巨噬细胞在其进展中,支持先天免疫系统在评估发病机理中的作用。
尽管使用量增加了,目前对烟的影响对肺部免疫学和生理学的影响知之甚少。
强调需要动物模型更好地理解其影响。小动物模型已显示
暴露于气溶胶的病理变化;但是,它们不会概括病理学
人类报道的评估表现形式需要一个更可翻译的动物模型来研究
评估的发病机理。非人类灵长类动物(NHP)非常适合研究呼吸道疾病
人类由于它们在肺部解剖结构和免疫学方面的相似性,这比其他人具有优势
动物模型。在这里,我们旨在利用NHP模型来研究烟雾气体暴露对
先天肺防御机制。我们将纵向评估肺部和先天免疫功能
(免疫细胞浸润,肺泡巨噬细胞吞噬作用,细胞因子,趋化因子和分泌
防御分子)在每天的每日蒸气气雾剂暴露期间。在研究结束时,相关性
随着病理的变化,将通过严格的验尸检查和上部和
下呼吸道。这项研究产生的数据将告知蒸发气溶胶的机制
影响先天肺防御,这是在高度感染性呼吸的时候进行的重要调查领域
疾病。此外,这项研究将为未来的研究提供初步数据,以评估贡献
烟液(尼古丁,四氢大麻酚和维生素E乙酸)中的个体成分的;和
在合并条件(SARS-COV-2和HIV/SIV)的背景下进行烟,特别感兴趣的领域由
几个资金机构(NIDA,NHLBI,NIAID)。这项拟议的研究和指导的职业发展计划
将在Drs的指导下在图兰国家灵长类动物研究中心进行。罗纳德·韦兹(Ronald Veazey)
和乍得·罗伊。 TNPRC一直是国家资源和生物医学研究卓越中心
使用非人类灵长类动物超过50年。 TNPRC对培训和指导有坚定的承诺
并提供支持(基于财务和努力),以创造早期阶段丰富多样的培训环境
调查人员。 TNPRC完全支持布莱尔博士的职业生涯目标,以发展为独立资助的
使用NHP模型研究的私人研究人员研究了主要公共健康重要性的疾病。专用
该K01提供的时间和其他指导将帮助布莱尔博士完善他的赠款写作和项目
管理技能,以确保他未来的R01提案的成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Robert Blair的其他基金
The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
电子烟气溶胶暴露对非人灵长类动物先天肺防御机制的影响
- 批准号:1059449910594499
- 财政年份:2022
- 资助金额:$ 20.05万$ 20.05万
- 项目类别:
Automated Staining Platform for Immunohistochemistry and In Situ Hybridization
用于免疫组织化学和原位杂交的自动化染色平台
- 批准号:1017725710177257
- 财政年份:2021
- 资助金额:$ 20.05万$ 20.05万
- 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
CNS-mediated fever after Adolescent Intermittent Ethanol
青少年间歇性饮酒后中枢神经系统介导的发热
- 批准号:1060715410607154
- 财政年份:2023
- 资助金额:$ 20.05万$ 20.05万
- 项目类别:
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)
识别儿童多系统炎症综合征 (MIS-C) 预后价值的生物标志物特征
- 批准号:1065153610651536
- 财政年份:2022
- 资助金额:$ 20.05万$ 20.05万
- 项目类别:
The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
电子烟气溶胶暴露对非人灵长类动物先天肺防御机制的影响
- 批准号:1059449910594499
- 财政年份:2022
- 资助金额:$ 20.05万$ 20.05万
- 项目类别:
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)
COVID-19 网络网络扩展预测儿童严重疾病的临床和转化方法(CONNECT 预测患病儿童)
- 批准号:1084782710847827
- 财政年份:2021
- 资助金额:$ 20.05万$ 20.05万
- 项目类别:
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)
识别儿童多系统炎症综合征 (MIS-C) 预后价值的生物标志物特征
- 批准号:1032049110320491
- 财政年份:2021
- 资助金额:$ 20.05万$ 20.05万
- 项目类别: